# Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation

> **NCT04467086** · PHASE3 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 72 (actual)

## Conditions studied

- Mechanical Ventilation
- Sedation
- Critical Illness
- COVID

## Interventions

- **DRUG:** Propranolol Hydrochloride

## Key facts

- **NCT ID:** NCT04467086
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-08
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2022-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467086, "Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04467086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*